Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MREO
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 19, 2026 | MREO Mereo BioPharma Group plc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 11, 2026 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 11, 2026 | MREO Mereo BioPharma Group plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2026 | MREO Mereo BioPharma Group plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 14, 2026 | MREO Mereo BioPharma Group plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2026 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K/A | 8-K ↗ |
| May 12, 2026 | MREO Mereo BioPharma Group plc | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Mar 27, 2026 | MREO Mereo BioPharma Group plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 19, 2026 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 17, 2026 | MREO Mereo BioPharma Group plc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 12, 2026 | MREO Mereo BioPharma Group plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 12, 2026 | MREO Mereo BioPharma Group plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 29, 2025 | MREO Mereo BioPharma Group plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 29, 2025 | MREO Mereo BioPharma Group plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2025 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 10, 2025 | MREO Mereo BioPharma Group plc | 8.01 Other Events | 8-K | 8-K ↗ |
| May 14, 2025 | MREO Mereo BioPharma Group plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 26, 2025 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | MREO Mereo BioPharma Group plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | MREO Mereo BioPharma Group plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2024 | MREO Mereo BioPharma Group plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
24 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances